Nishani Jayanika Jayathilake
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nishani Jayanika Jayathilake has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Kyu Pil Lee
Department of Veterinary Physiology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea
3 shared publications - Beno Ramesh Nirujan
Department of Veterinary Physiology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea
2 shared publications - Akila Cooray
Department of Physiology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Korea
1 shared publication - Andrew William Taylor-Robinson
College of Health Sciences, VinUniversity, Hanoi, Vietnam
1 shared publication - Eun Bok Baek
Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea
1 shared publication - Hyo Seong Ji
Huons Foodience Co., Ltd., Geumsan 32724, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 12 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (3) , 400
Ameliorative Effects of Prunella vulgaris on Lower Urinary Tract Symptoms Induced by Benign Prostatic Hyperplasia in SD Rats via Nitric Oxide and Potassium Channels
Background: Lower urinary tract symptoms (LUTS) due to prostate hyperplasia are the most frequent urological symptoms in elderly men. Current pharmacological treatments for LUTS and benign prostatic hyperplasia (BPH) are widely used in clinical practice; however, adverse effects associated with these drugs have been reported for sexual dysfunction and orthostatic hypotension. Prunella vulgaris (PV) is a medicinal herb that has a long history of use. This study aimed to address this gap by investigating the relaxant activity of PV extract (PVE) on rat prostate smooth muscle ex vivo and evaluating intravesical cystometry for its potential. Methods and Results: Ten male Sprague Dawley (SD) rats were used to study the relaxant efficacy of PVE and its constituents in isometric contraction ex vivo. Thirty-six SD rats were randomly assigned to six groups of six animals (n = 6) and administered testosterone propionate (TP; 3 mg/kg) daily for 4 weeks to induce BPH. Groups of BPH rats were treated with or without PVE (30, 60, or 90 mg/kg) via oral gavage. At the end of the experiments, the animals were subjected to intravesical pressure under urethane anesthesia. After successful cystometric recording, rats were euthanized with carbon dioxide. Prostate and bladder tissues were harvested and processed for histological and biochemical analysis. The results demonstrated that PVE exerted relaxant effects on prostatic smooth muscle in a concentration-dependent manner, mediated by nitric oxide and potassium channels, without antagonizing adrenergic receptors. Additionally, intravesical cystometry in SD rats treated with oral gavage of PVE for 4 weeks showed a significant improvement in voiding abnormalities. Conclusions: These findings suggest the potential of PV and its compounds as a therapeutic strategy to improve LUTS associated with BPH.
- 12 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (3) , 400
Open AccessAmeliorative Effects of Prunella vulgaris on Lower Urinary Tract Symptoms Induced by Benign Prostatic Hyperplasia in SD Rats via Nitric Oxide and Potassium Channels
Background: Lower urinary tract symptoms (LUTS) due to prostate hyperplasia are the most frequent urological symptoms in elderly men. Current pharmacological treatments for LUTS and benign prostatic hyperplasia (BPH) are widely used in clinical practice; however, adverse effects associated with these drugs have been reported for sexual dysfunction and orthostatic hypotension. Prunella vulgaris (PV) is a medicinal herb that has a long history of use. This study aimed to address this gap by investigating the relaxant activity of PV extract (PVE) on rat prostate smooth muscle ex vivo and evaluating intravesical cystometry for its potential. Methods and Results: Ten male Sprague Dawley (SD) rats were used to study the relaxant efficacy of PVE and its constituents in isometric contraction ex vivo. Thirty-six SD rats were randomly assigned to six groups of six animals (n = 6) and administered testosterone propionate (TP; 3 mg/kg) daily for 4 weeks to induce BPH. Groups of BPH rats were treated with or without PVE (30, 60, or 90 mg/kg) via oral gavage. At the end of the experiments, the animals were subjected to intravesical pressure under urethane anesthesia. After successful cystometric recording, rats were euthanized with carbon dioxide. Prostate and bladder tissues were harvested and processed for histological and biochemical analysis. The results demonstrated that PVE exerted relaxant effects on prostatic smooth muscle in a concentration-dependent manner, mediated by nitric oxide and potassium channels, without antagonizing adrenergic receptors. Additionally, intravesical cystometry in SD rats treated with oral gavage of PVE for 4 weeks showed a significant improvement in voiding abnormalities. Conclusions: These findings suggest the potential of PV and its compounds as a therapeutic strategy to improve LUTS associated with BPH.
- Top Cited PapersOpen Access
- 3 March 2025
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 57 (3) , 501-514
Modulating neuroplasticity for chronic pain relief: noninvasive neuromodulation as a promising approach
Chronic neuropathic pain is a debilitating neuroplastic disorder that notably impacts the quality of life of millions of people worldwide. This complex condition, encompassing various manifestations, such as sciatica, diabetic neuropathy and postherpetic neuralgia, arises from nerve damage or malfunctions in pain processing pathways and involves various biological, physiological and psychological processes. Maladaptive neuroplasticity, known as central sensitization, plays a critical role in the persistence of chronic neuropathic pain. Current treatments for neuropathic pain include pharmacological interventions (for example, antidepressants and anticonvulsants), invasive procedures (for example, deep brain stimulation) and physical therapies. However, these approaches often have limitations and potential side effects. In light of these challenges, interest in noninvasive neuromodulation techniques as alternatives or complementary treatments for neuropathic pain is increasing. These methods aim to induce analgesia while reversing maladaptive plastic changes, offering potential advantages over conventional pharmacological practices and invasive methods. Recent technological advancements have spurred the exploration of noninvasive neuromodulation therapies, such as repetitive transcranial magnetic stimulation, transcranial direct current stimulation and transcranial ultrasound stimulation, as well as innovative transformations of invasive techniques into noninvasive methods at both the preclinical and clinical levels. Here this review aims to critically examine the mechanisms of maladaptive neuroplasticity in chronic neuropathic pain and evaluate the efficacy of noninvasive neuromodulation techniques in pain relief. By focusing on optimizing these techniques, we can better assess their short-term and long-term effects, refine treatment variables and ultimately improve the quality of neuropathic pain management.
- 3 March 2025
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 57 (3) , 501-514
Top Cited PapersOpen AccessModulating neuroplasticity for chronic pain relief: noninvasive neuromodulation as a promising approach
Chronic neuropathic pain is a debilitating neuroplastic disorder that notably impacts the quality of life of millions of people worldwide. This complex condition, encompassing various manifestations, such as sciatica, diabetic neuropathy and postherpetic neuralgia, arises from nerve damage or malfunctions in pain processing pathways and involves various biological, physiological and psychological processes. Maladaptive neuroplasticity, known as central sensitization, plays a critical role in the persistence of chronic neuropathic pain. Current treatments for neuropathic pain include pharmacological interventions (for example, antidepressants and anticonvulsants), invasive procedures (for example, deep brain stimulation) and physical therapies. However, these approaches often have limitations and potential side effects. In light of these challenges, interest in noninvasive neuromodulation techniques as alternatives or complementary treatments for neuropathic pain is increasing. These methods aim to induce analgesia while reversing maladaptive plastic changes, offering potential advantages over conventional pharmacological practices and invasive methods. Recent technological advancements have spurred the exploration of noninvasive neuromodulation therapies, such as repetitive transcranial magnetic stimulation, transcranial direct current stimulation and transcranial ultrasound stimulation, as well as innovative transformations of invasive techniques into noninvasive methods at both the preclinical and clinical levels. Here this review aims to critically examine the mechanisms of maladaptive neuroplasticity in chronic neuropathic pain and evaluate the efficacy of noninvasive neuromodulation techniques in pain relief. By focusing on optimizing these techniques, we can better assess their short-term and long-term effects, refine treatment variables and ultimately improve the quality of neuropathic pain management.
- Open Access
- 25 April 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (9) , 7806
Pharmacological Evidence Suggests That Slo3 Channel Is the Principal K+ Channel in Boar Spermatozoa
Sperm ion channels are associated with the quality and type of flagellar movement, and their differential regulation is crucial for sperm function during specific phases. The principal potassium ion channel is responsible for the majority of K+ ion flux, resulting in membrane hyperpolarization, and is essential for sperm capacitation-related signaling pathways. The molecular identity of the principal K+ channel varies greatly between different species, and there is a lack of information about boar K+ channels. We aimed to determine the channel identity of boar sperm contributing to the primary K+ current using pharmacological dissection. A series of Slo1 and Slo3 channel modulators were used for treatment. Sperm motility and related kinematic parameters were monitored using a computer-assisted sperm analysis system under non-capacitated conditions. Time-lapse flow cytometry with fluorochromes was used to measure changes in different intracellular ionic concentrations, and conventional flow cytometry was used to determine the acrosome reaction. Membrane depolarization, reduction in acrosome reaction, and motility parameters were observed upon the inhibition of the Slo3 channel, suggesting that the Slo3 gene encodes the main K+ channel in boar spermatozoa. The Slo3 channel was localized on the sperm flagellum, and the inhibition of Slo3 did not reduce sperm viability. These results may aid potential animal-model-based extrapolations and help to ameliorate motility and related parameters, leading to improved assisted reproductive methods in industrial livestock production.
- 25 April 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (9) , 7806
Open AccessPharmacological Evidence Suggests That Slo3 Channel Is the Principal K+ Channel in Boar Spermatozoa
Sperm ion channels are associated with the quality and type of flagellar movement, and their differential regulation is crucial for sperm function during specific phases. The principal potassium ion channel is responsible for the majority of K+ ion flux, resulting in membrane hyperpolarization, and is essential for sperm capacitation-related signaling pathways. The molecular identity of the principal K+ channel varies greatly between different species, and there is a lack of information about boar K+ channels. We aimed to determine the channel identity of boar sperm contributing to the primary K+ current using pharmacological dissection. A series of Slo1 and Slo3 channel modulators were used for treatment. Sperm motility and related kinematic parameters were monitored using a computer-assisted sperm analysis system under non-capacitated conditions. Time-lapse flow cytometry with fluorochromes was used to measure changes in different intracellular ionic concentrations, and conventional flow cytometry was used to determine the acrosome reaction. Membrane depolarization, reduction in acrosome reaction, and motility parameters were observed upon the inhibition of the Slo3 channel, suggesting that the Slo3 gene encodes the main K+ channel in boar spermatozoa. The Slo3 channel was localized on the sperm flagellum, and the inhibition of Slo3 did not reduce sperm viability. These results may aid potential animal-model-based extrapolations and help to ameliorate motility and related parameters, leading to improved assisted reproductive methods in industrial livestock production.
- Open Access
- 29 October 2020
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Infectious Diseases
- Vol. 10 (2) , 114
Leishmaniasis in Sri Lanka: The need for effective targeting of island-specific issues through strategic implementation of global management plans for disease detection and control
Leishmaniasis, a vector-borne parasitic disease caused by Leishmania sp., has become a considerable global public health burden in recent decades, such that it is recognized by the World Health Organization as one of eight major neglected tropical parasitic diseases worldwide. The causative protozoan parasite is detected on every continent except Antarctica. There are three clinically distinct forms of leishmaniasis: cutaneous, mucocutaneous and visceral, the latter being the most serious manifestation. In Sri Lanka, at the turn of this century, leishmaniasis was limited initially to a few imported cases but it is now a growing healthcare concern that is endemic to almost all districts. In particular, Hambantota, Matara, Kurunegala and Anuradhapura are seriously affected. Socioeconomic conditions, population mobility, environmental and climate changes are each considered important influences on the prevalence of leishmaniasis throughout the island nation. However, significant knowledge gaps remain regarding the precise epidemiology and severity of the disease, in large part due to the asymptomatic nature of the infection. Development of effective diagnostic tools, mapping disease distribution in unexplored locations and implementation of strategic management plans are all needed to meet the formidable challenge of eliminating leishmaniasis from Sri Lanka.
- 29 October 2020
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Infectious Diseases
- Vol. 10 (2) , 114
Open AccessLeishmaniasis in Sri Lanka: The need for effective targeting of island-specific issues through strategic implementation of global management plans for disease detection and control
Leishmaniasis, a vector-borne parasitic disease caused by Leishmania sp., has become a considerable global public health burden in recent decades, such that it is recognized by the World Health Organization as one of eight major neglected tropical parasitic diseases worldwide. The causative protozoan parasite is detected on every continent except Antarctica. There are three clinically distinct forms of leishmaniasis: cutaneous, mucocutaneous and visceral, the latter being the most serious manifestation. In Sri Lanka, at the turn of this century, leishmaniasis was limited initially to a few imported cases but it is now a growing healthcare concern that is endemic to almost all districts. In particular, Hambantota, Matara, Kurunegala and Anuradhapura are seriously affected. Socioeconomic conditions, population mobility, environmental and climate changes are each considered important influences on the prevalence of leishmaniasis throughout the island nation. However, significant knowledge gaps remain regarding the precise epidemiology and severity of the disease, in large part due to the asymptomatic nature of the infection. Development of effective diagnostic tools, mapping disease distribution in unexplored locations and implementation of strategic management plans are all needed to meet the formidable challenge of eliminating leishmaniasis from Sri Lanka.
- Open Access
- 1 January 2020
- Published by Taylor & Francis in The European Zoological Journal
- Vol. 87 (1) , 708-713
Cnidarian toxins: recent evidences for potential therapeutic uses
Marine toxins have received global attention for their involvement in human intoxication. Many marine phyla are well adapted to produce venoms or toxins protect themselves from associated micro fauna, predators and pathogens. Despite the toxicity, some bio toxins stand as potential drug leads in human and veterinary medicine. Amongst all marine fauna, Cnidarians are well renowned for producing bioactive peptides which are used in drug development, as they harbor various biological activities; anticancer, anti-inflammatory, immunomodulatory, radical scavenging, anti-parasitic activities, etc. Particularly, this review summarizes the bioactivities recorded from Cnidarian toxins and the possibility of using them as therapeutic agents, leading to develop into commercial products in the future.
- 1 January 2020
- Published by Taylor & Francis in The European Zoological Journal
- Vol. 87 (1) , 708-713
Open AccessCnidarian toxins: recent evidences for potential therapeutic uses
Marine toxins have received global attention for their involvement in human intoxication. Many marine phyla are well adapted to produce venoms or toxins protect themselves from associated micro fauna, predators and pathogens. Despite the toxicity, some bio toxins stand as potential drug leads in human and veterinary medicine. Amongst all marine fauna, Cnidarians are well renowned for producing bioactive peptides which are used in drug development, as they harbor various biological activities; anticancer, anti-inflammatory, immunomodulatory, radical scavenging, anti-parasitic activities, etc. Particularly, this review summarizes the bioactivities recorded from Cnidarian toxins and the possibility of using them as therapeutic agents, leading to develop into commercial products in the future.